Protagonist Therapeutics
PTGX
PTGX
66 hedge funds and large institutions have $208M invested in Protagonist Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 64 → 66 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
66
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.01M | |
| 2 | +$7.16M | |
| 3 | +$4.04M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.33M |
| 5 |
VMI
VHCP Management III
New York
|
+$3.19M |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$3.51M | |
| 3 | -$3.05M | |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$1.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.18M |